Detalles de la búsqueda
1.
Sequential combination therapy with pegylated interferon leads to loss of hepatitis B surface antigen and hepatitis B e antigen (HBeAg) seroconversion in HBeAg-positive chronic hepatitis B patients receiving long-term entecavir treatment.
Antimicrob Agents Chemother
; 59(7): 4121-8, 2015 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-25941216
Resultados
1 -
1
de 1
1
Próxima >
>>